Abstract
Excitotoxic neuronal death, associated with neurodegeneration and stroke, is triggered primarily by massive Ca2+ influx arising from overactivation of glutamate receptor channels of the N-methyl-D-aspartate (NMDA) subtype. To search for channel blockers, synthetic combinatorial libraries were assayed for block of agonist-evoked currents by the human NR1-NR2A NMDA receptor subunits expressed in amphibian oocytes. A set of arginine-rich hexapeptides selectively blocked the NMDA receptor channel with IC50, approximately 100 nM, a potency similar to clinically tolerated blockers such as memantine, and only marginally blocked on non-NMDA glutamate receptors. These peptides prevent neuronal cell death elicited by an excitotoxic insult on hippocampal cultures.
Access options
Subscribe to Journal
Get full journal access for 1 year
$259.00
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1
Choi, D.W. and Rothman, S.M. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13: 171–182.
- 2
Choi, D.W. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18: 58–60.
- 3
Nicotera, P., Ankarcrona, M., Bonfoco, E., Orrenius, S. and Lipton, S.A. 1997. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neural. 72: 95–101.
- 4
Golstein, P. 1997. Controlling cell death. Science 275: 1081–1082.
- 5
Snyder, S.H. 1996. No NO prevents parkinsonism. Nature Med.. 2: 965–966.
- 6
Dawson, T.M. and Dawson, V.L. 1996. Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Annu. Rev. Med. 47: 219–227.
- 7
Schinder, A.F., Olson, E.C., Spitzer, N.C. and Montal, M. 1996. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16: 6125–6133.
- 8
Chen, H.-S., Pellegrini, J.W., Aggarwal, S.K., Lei, F.Z., Warach, S., Jensen, R.E. et al. 1992. Open channel block of the N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12: 4427–4436.
- 9
Houghten, R.A., Pinilla, C., Blondelle, S.E., Appel, J.R., Dooley, C.T., Cuervo J.H. et al. 1991. Generation and use of synthetic peptide combinatorial libraries for basic research and drug delivery. Nature 354: 84–86.
- 10
Pinilla, C., Appel, J.R., Blanc, P. and Houghten, R.A. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques 13: 901–905.
- 11
Burnashev, N., Schoepfer, R., Monyer, H., Ruppersberg, J.P., Günther, P., Seeburg, P.M. and Sakmann, B. 1992. Control by asparagine residues of calcium permeability and magnessium blockade in the NMDA receptor. Science 257: 1415–1419.
- 12
Wong, E.H., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N., Iversen, L.L. et al. 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83: 7104–7108.
- 13
Huettner, J.E. and Bean, B.P. 1988. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl. Acad. Sci. USA 85: 1307–1311.
- 14
Premkumar, L.S. and Auerbach, A. 1996. Identification of a high affinity divalent cation binding site near the entrance of the NMDA receptor channel. Neuron 16: 869–880.
- 15
Avénet, P., Léonardon, J., Besnard, F., Graham, D., Frost, J., Depoortere, H. et al. 1996. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur. J. Pharmacol. 296: 209–213.
- 16
Mèziére, C., Viguier, M., Dumortier, H., Lo-Man, R., Leclerc, C., Guillet, J.G. et al. 1997. In vivo T helper cell response to retro-inverso peptidomimetics. J. Immunol. 159: 3230–3237.
- 17
Li, M. et al. 1996. In vitro selection of peptides acting at a new site of NMDA glutamate receptors. Bio/Technology 14: 986–991.
- 18
Steiner, J.P., Hamilton, G.S., Ross, D.T., Valentine, H.L., Guo, H., Connolly, M.A. et al. 1997. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA 94: 2019–2024.
- 19
Hara, H., Friedlander, R.M., Gagliardini, V., Ayata, C., Fink, K., Huang, Z. et al. 1997. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94: 2007–2012.
- 20
Hunter, A.J. 1997. Calcium antagonists: their role in neuroprotection. Int. Rev. Neurobiol. 40: 95–108.
- 21
Lyden, P.D. 1997. GABA and neuroprotection. Int. Rev. Neurobiol. 40: 233–258.
- 22
Grilli, M., Pizzi, M., Memo, M. and Spano, P. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science 274: 1383–1385.
- 23
McBurney, R.W. 1997. Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury. Int. Rev. Neurobiol. 40: 173–195.
- 24
Parsons, C.G., Panchenko, V.A., Pinchenko, V.O., Tsyndrenko, A.Y. and Krishtal, O.A. 1996. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci. 8: 446–454.
- 25
Herrero, J.F., Headley, P.M. and Parsons, C.G. 1994. Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo. Neurosci. Lett. 165: 37–40.
- 26
Vorwerk, C.K., Lipton, S.A., Zurakowski, D., Hyman, B.T., Sabel, B.A., Dreyer, E.B. et al. 1996. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37: 1618–1624.
- 27
Kochhar, A., Zivin, J.A., Lyden, P.D. and Mazzarella, V. 1988. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45: 148–153.
- 28
Weseman, W., Sturn, G. and Fünfgeld, E.W. 1980. Distribution and metabolism of the potential anti-Parkinson drug memantine in the human. J. Neural Transm. Suppl. 16: 143–148.
- 29
Kornhuber, J. and Weller, M. 1997. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol. Psychiatry 41: 135–144.
- 30
Kornhuber, J. and Quack, G. 1995. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci. Lett. 195: 137–139.
- 31
Dooley, C.T., Chung, N.N., Wilkes, B.C., Schiller, P.W., Bidlack, J.M., Pasternak, G.W. et al. 1994. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science 266: 2019–2022.
- 32
Houghten, R.A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82: 5131–5135.
- 33
Ostresh, J.M., Winkle, J.H., Hamashin, V.T. and Houghten, R.A. 1994. Peptide libraries: Determination of relative reaction rates of protected amino acids in competitive couplings. Biopolymers 34: 1681–1689.
- 34
Tam, J.P., Heath, W.F. and Merrifield, R.B. 1983. SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. Journal of the American Chemical Society 105: 6442–6455.
- 35
Houghten, R.A., Bray, M.K., De Graw, S.T. and Kirby, C.J. 1986. Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. Int. J. Pept. Protein Res. 27: 673–678.
- 36
Ferrer-Montiel, A.V. and Montal, M. 1994. Structure-function relations in ligand-gated ion channels: Reconstitution in lipid bilayers and heterologous expression in Xenopus oocytes. Methods: A Companion to Methods in Enzymology 6: 60–69.
- 37
Ferrer-Montiel, A.V., Sun, W. and Montal, M. 1995. Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine. Proc. Natl. Acad. Sci. USA 92: 8021–8025.
- 38
Ferrer-Montiel, A.V., Sun, W. and Montal, M. 1996. A single tryptophan on M2 of glutamate receptor channels confers high permeability to divalent cations. Biophys. J. 71: 749–758.
- 39
Sun, W., Ferrer-Montiel, A.V., Schinder, A.F., McPherson, J.P., Evans, G.A., Montal, M. et al. 1992. Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors. Proc. Natl. Acad. Sci. USA 89: 1443–1447.
- 40
Planells-Cases, R., Sun, W., Ferrer-Montiel, A.V. and Montal, M. 1993. Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain. Proc. Natl. Acad. Sci. USA 90: 5057–5061.
- 41
Le Bourdelles, B., Wafford, K.A., Kemp, J.A., Marshall, G., Bain, C., Wilcox, A.S. et al. 1994. Cloning, functional expression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J. Neurochem. 62: 2091–2098.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferrer-Montiel, A., Merino, J., Blondelle, S. et al. Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death. Nat Biotechnol 16, 286–291 (1998). https://doi.org/10.1038/nbt0398-286
Received:
Accepted:
Issue Date:
Further reading
-
Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
Frontiers in Neurology (2020)
-
Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model
Neurotherapeutics (2020)
-
Effect of Polyarginine Peptide R18D Following a Traumatic Brain Injury in Sprague-Dawley Rats
Current Therapeutic Research (2020)
-
Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function
Molecules (2020)
-
Poly-Arginine Peptides R18 and R18D Improve Functional Outcomes After Endothelin-1-Induced Stroke in the Sprague Dawley Rat
Journal of Neuropathology & Experimental Neurology (2019)